Immunotherapies | Community Health

Immunotherapies are a class of treatments that leverage the immune system to prevent, control, or eliminate diseases, including cancer, autoimmune disorders, and infectious diseases. By stimulating or modulating the immune response, immunotherapies offer a promising approach to targeting specific cells or pathways, reducing inflammation, and promoting healing. With a rich history dating back to the late 19th century, immunotherapies have evolved significantly, incorporating advances in genetics, biotechnology, and our understanding of the immune system. Today, immunotherapies are being explored for a wide range of applications, from cancer treatment to vaccine development, and have shown remarkable potential in improving patient outcomes. According to the [[national-cancer-institute|National Cancer Institute]], immunotherapies have been shown to be effective in treating various types of cancer, including melanoma, lung cancer, and kidney cancer. The [[food-and-drug-administration|FDA]] has also approved several immunotherapies for the treatment of cancer and other diseases, including [[pembrolizumab|Pembrolizumab]] and [[nivolumab|Nivolumab]].